Sensitizing tumor response to topoisomerase I antibody-drug conjugate by selective CDK7 inhibition
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
By suppressing RNAPII transition from initiation to elongation and DNA repair pathways, Q901 stabilizes TOP1-DPCs and sensitizes tumors to TOP1 inhibitors.
Appeared: Friday, October 2. Science Advances. Peer-reviewed journal.